Rhoa-KO Mouse
Common Name
Rhoa-KO
제품 ID
S-KO-01130
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-11848-Rhoa-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Rhoa-KO Mouse (카탈로그 번호 S-KO-01130)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Rhoa-KO
품종 계통계통 ID
KOCMP-11848-Rhoa-B6J-VA
유전자명
제품 ID
S-KO-01130
유전자 별칭
Arha, Arha1, Arha2
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 9
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000007959
NCBI 전사체 ID
NM_016802.5
타겟 영역
Exon 4
유효 영역 크기
~1.2 kb
유전자 연구 개요
RhoA, short for Ras homolog gene family member A, is a small GTPase of the Rho family. It plays a pivotal role in regulating multiple signal transduction pathways, influencing diverse cellular functions such as cell survival, migration, adhesion, proliferation, and cytoskeletal dynamics [1,2]. The RhoA/ROCK signaling pathway is associated with numerous biological processes, including those in the nervous system [5,6]. Genetic models, like KO/CKO mouse models, are valuable for studying RhoA's functions.
Aberrant RhoA signaling has been implicated in neurodegenerative diseases such as Parkinson's, Alzheimer's, Huntington's, and amyotrophic lateral sclerosis. In Alzheimer's, the RhoA/ROCK signaling pathway promotes the disease's occurrence, for example, ROCK activation increases β -secretase activity and Aβ production, and Aβ further activates ROCK [1,6]. In cancer, RHOA may act as both an oncogene and a tumor suppressor, with mutations in RHOA identified in primary leukemia/lymphoma and gastric cancer [2,3,4]. In capillary malformation-arteriovenous malformation syndrome, loss of RASA1 function may lead to constitutive activation of RhoA signaling in endothelial cells, increasing vascular permeability [7]. Also, RhoA is crucial for myoblast fusion, as its absence in satellite cells prevents proper fusion during muscle regeneration and hypertrophy [8]. Additionally, RhoA has a role in DNA damage response, with components like ATM, FEN1, and ROS regulating its activation, and it mediates cell cycle arrest [9].
In conclusion, RhoA is essential in regulating various cellular functions and signaling pathways. Model-based research, especially KO/CKO mouse models, has revealed its significance in neurodegenerative diseases, cancers, vascular syndromes, muscle regeneration, and DNA damage response. Understanding RhoA's functions provides insights into the mechanisms of these biological processes and diseases, potentially guiding the development of new therapeutic strategies.
References:
1. Schmidt, Sissel Ida, Blaabjerg, Morten, Freude, Kristine, Meyer, Morten. 2022. RhoA Signaling in Neurodegenerative Diseases. In Cells, 11, . doi:10.3390/cells11091520. https://pubmed.ncbi.nlm.nih.gov/35563826/
2. Santos, Juliana Carvalho, Profitós-Pelejà, Núria, Sánchez-Vinces, Salvador, Roué, Gaël. 2023. RHOA Therapeutic Targeting in Hematological Cancers. In Cells, 12, . doi:10.3390/cells12030433. https://pubmed.ncbi.nlm.nih.gov/36766776/
3. Schaefer, Antje, Der, Channing J. 2022. RHOA takes the RHOad less traveled to cancer. In Trends in cancer, 8, 655-669. doi:10.1016/j.trecan.2022.04.005. https://pubmed.ncbi.nlm.nih.gov/35568648/
4. Benton, Dorothy, Chernoff, Jonathan. 2023. RHOA drivers take alternate routes in gastric cancer. In Science signaling, 16, eadk9171. doi:10.1126/scisignal.adk9171. https://pubmed.ncbi.nlm.nih.gov/38113334/
5. Lu, Weizhuo, Chen, Zhiwu, Wen, Jiyue. 2021. RhoA/ROCK signaling pathway and astrocytes in ischemic stroke. In Metabolic brain disease, 36, 1101-1108. doi:10.1007/s11011-021-00709-4. https://pubmed.ncbi.nlm.nih.gov/33745103/
6. Cai, RuoLan, Wang, YangYang, Huang, ZhenTing, Yu, Changyin, Cai, Zhiyou. 2021. Role of RhoA/ROCK signaling in Alzheimer's disease. In Behavioural brain research, 414, 113481. doi:10.1016/j.bbr.2021.113481. https://pubmed.ncbi.nlm.nih.gov/34302876/
7. Eisa-Beygi, Shahram, Vo, Nghia Jack, Link, Brian A. 2020. RhoA activation-mediated vascular permeability in capillary malformation-arteriovenous malformation syndrome: a hypothesis. In Drug discovery today, 26, 1790-1793. doi:10.1016/j.drudis.2020.12.012. https://pubmed.ncbi.nlm.nih.gov/33358701/
8. Noviello, Chiara, Kobon, Kassandra, Randrianarison-Huetz, Voahangy, Falcone, Sestina, Sotiropoulos, Athanassia. 2023. RhoA Is a Crucial Regulator of Myoblast Fusion. In Cells, 12, . doi:10.3390/cells12232673. https://pubmed.ncbi.nlm.nih.gov/38067102/
9. Cheng, Chibin, Seen, Daniel, Zheng, Chunwen, Zeng, Ruijie, Li, Enmin. 2021. Role of Small GTPase RhoA in DNA Damage Response. In Biomolecules, 11, . doi:10.3390/biom11020212. https://pubmed.ncbi.nlm.nih.gov/33546351/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
